Atrial natriuretic peptide inhibits angiotensin II-stimulated proliferation in fetal cardiomyocytes

    Research output: Contribution to journalArticle

    28 Citations (Scopus)

    Abstract

    The role of atrial natriuretic peptide (ANP) in regulating fetal cardiac growth is poorly understood. Angiotensin II (Ang II) stimulates proliferation in fetal sheep cardiomyocytes when growth is dependent on the activity of the mitogen-activated protein kinase (MAPK) and phosphoinositol-3-kinase (PI3K) pathways. We hypothesized that ANP would suppress near-term fetal cardiomyocyte proliferation in vitro and inhibit both the MAPK and PI3K pathways. Forty-eight hour 5-bromodeoxyuridine (BrdU) uptake (used as an index of proliferation) was measured in cardiomyocytes isolated from fetal sheep (135 day gestational age) in response to 100 nmAng IIwith orwithoutANP(0.003-100 nm) or 1 μm8-bromo-cGMP. The effects of these compounds on the MAPK and PI3K pathways were assessed by measuring extracellular signal-regulated kinase (ERK) and AKT phosphorylation following 10 min of treatment with Ang II, ANP or 8-bromo-cGMP. In right ventricular myocytes (RV), the lowest dose of ANP (0.003 nm) inhibited Ang II-stimulated BrdU uptake by 68%. Similarly, 8-bromo-cGMP suppressed Ang II-stimulated proliferation by 62%. The same effects were observed in left ventricular (LV) cardiomyoytes but the RV was more sensitive to the inhibitory effects of ANP than the LV (P <0.0001). Intracellular cGMP was increased by 4-fold in the presence of 100 nm ANP. Ang II-stimulated ERK and Akt phosphorylation was inhibited by 100 nm ANP. The activity of ANP may in part be cGMP dependent, as 8-bromo-cGMP had similar effects on the cardiomyocytes.

    Original languageEnglish (US)
    Pages (from-to)2879-2889
    Number of pages11
    JournalJournal of Physiology
    Volume588
    Issue number15
    DOIs
    StatePublished - Aug 2010

    Fingerprint

    Atrial Natriuretic Factor
    Cardiac Myocytes
    Angiotensin II
    MAP Kinase Kinase 3
    Extracellular Signal-Regulated MAP Kinases
    Bromodeoxyuridine
    Muscle Cells
    Sheep
    Phosphorylation
    Fetal Development
    Gestational Age
    Growth
    8-bromocyclic GMP

    ASJC Scopus subject areas

    • Physiology
    • Medicine(all)

    Cite this

    @article{e36d7ad48ebc45308148a5dd885a0b15,
    title = "Atrial natriuretic peptide inhibits angiotensin II-stimulated proliferation in fetal cardiomyocytes",
    abstract = "The role of atrial natriuretic peptide (ANP) in regulating fetal cardiac growth is poorly understood. Angiotensin II (Ang II) stimulates proliferation in fetal sheep cardiomyocytes when growth is dependent on the activity of the mitogen-activated protein kinase (MAPK) and phosphoinositol-3-kinase (PI3K) pathways. We hypothesized that ANP would suppress near-term fetal cardiomyocyte proliferation in vitro and inhibit both the MAPK and PI3K pathways. Forty-eight hour 5-bromodeoxyuridine (BrdU) uptake (used as an index of proliferation) was measured in cardiomyocytes isolated from fetal sheep (135 day gestational age) in response to 100 nmAng IIwith orwithoutANP(0.003-100 nm) or 1 μm8-bromo-cGMP. The effects of these compounds on the MAPK and PI3K pathways were assessed by measuring extracellular signal-regulated kinase (ERK) and AKT phosphorylation following 10 min of treatment with Ang II, ANP or 8-bromo-cGMP. In right ventricular myocytes (RV), the lowest dose of ANP (0.003 nm) inhibited Ang II-stimulated BrdU uptake by 68{\%}. Similarly, 8-bromo-cGMP suppressed Ang II-stimulated proliferation by 62{\%}. The same effects were observed in left ventricular (LV) cardiomyoytes but the RV was more sensitive to the inhibitory effects of ANP than the LV (P <0.0001). Intracellular cGMP was increased by 4-fold in the presence of 100 nm ANP. Ang II-stimulated ERK and Akt phosphorylation was inhibited by 100 nm ANP. The activity of ANP may in part be cGMP dependent, as 8-bromo-cGMP had similar effects on the cardiomyocytes.",
    author = "O'Tierney, {P. F.} and Natasha Chattergoon and Samantha Louey and George Giraud and Kent Thornburg",
    year = "2010",
    month = "8",
    doi = "10.1113/jphysiol.2010.191098",
    language = "English (US)",
    volume = "588",
    pages = "2879--2889",
    journal = "Journal of Physiology",
    issn = "0022-3751",
    publisher = "Wiley-Blackwell",
    number = "15",

    }

    TY - JOUR

    T1 - Atrial natriuretic peptide inhibits angiotensin II-stimulated proliferation in fetal cardiomyocytes

    AU - O'Tierney, P. F.

    AU - Chattergoon, Natasha

    AU - Louey, Samantha

    AU - Giraud, George

    AU - Thornburg, Kent

    PY - 2010/8

    Y1 - 2010/8

    N2 - The role of atrial natriuretic peptide (ANP) in regulating fetal cardiac growth is poorly understood. Angiotensin II (Ang II) stimulates proliferation in fetal sheep cardiomyocytes when growth is dependent on the activity of the mitogen-activated protein kinase (MAPK) and phosphoinositol-3-kinase (PI3K) pathways. We hypothesized that ANP would suppress near-term fetal cardiomyocyte proliferation in vitro and inhibit both the MAPK and PI3K pathways. Forty-eight hour 5-bromodeoxyuridine (BrdU) uptake (used as an index of proliferation) was measured in cardiomyocytes isolated from fetal sheep (135 day gestational age) in response to 100 nmAng IIwith orwithoutANP(0.003-100 nm) or 1 μm8-bromo-cGMP. The effects of these compounds on the MAPK and PI3K pathways were assessed by measuring extracellular signal-regulated kinase (ERK) and AKT phosphorylation following 10 min of treatment with Ang II, ANP or 8-bromo-cGMP. In right ventricular myocytes (RV), the lowest dose of ANP (0.003 nm) inhibited Ang II-stimulated BrdU uptake by 68%. Similarly, 8-bromo-cGMP suppressed Ang II-stimulated proliferation by 62%. The same effects were observed in left ventricular (LV) cardiomyoytes but the RV was more sensitive to the inhibitory effects of ANP than the LV (P <0.0001). Intracellular cGMP was increased by 4-fold in the presence of 100 nm ANP. Ang II-stimulated ERK and Akt phosphorylation was inhibited by 100 nm ANP. The activity of ANP may in part be cGMP dependent, as 8-bromo-cGMP had similar effects on the cardiomyocytes.

    AB - The role of atrial natriuretic peptide (ANP) in regulating fetal cardiac growth is poorly understood. Angiotensin II (Ang II) stimulates proliferation in fetal sheep cardiomyocytes when growth is dependent on the activity of the mitogen-activated protein kinase (MAPK) and phosphoinositol-3-kinase (PI3K) pathways. We hypothesized that ANP would suppress near-term fetal cardiomyocyte proliferation in vitro and inhibit both the MAPK and PI3K pathways. Forty-eight hour 5-bromodeoxyuridine (BrdU) uptake (used as an index of proliferation) was measured in cardiomyocytes isolated from fetal sheep (135 day gestational age) in response to 100 nmAng IIwith orwithoutANP(0.003-100 nm) or 1 μm8-bromo-cGMP. The effects of these compounds on the MAPK and PI3K pathways were assessed by measuring extracellular signal-regulated kinase (ERK) and AKT phosphorylation following 10 min of treatment with Ang II, ANP or 8-bromo-cGMP. In right ventricular myocytes (RV), the lowest dose of ANP (0.003 nm) inhibited Ang II-stimulated BrdU uptake by 68%. Similarly, 8-bromo-cGMP suppressed Ang II-stimulated proliferation by 62%. The same effects were observed in left ventricular (LV) cardiomyoytes but the RV was more sensitive to the inhibitory effects of ANP than the LV (P <0.0001). Intracellular cGMP was increased by 4-fold in the presence of 100 nm ANP. Ang II-stimulated ERK and Akt phosphorylation was inhibited by 100 nm ANP. The activity of ANP may in part be cGMP dependent, as 8-bromo-cGMP had similar effects on the cardiomyocytes.

    UR - http://www.scopus.com/inward/record.url?scp=78751613726&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=78751613726&partnerID=8YFLogxK

    U2 - 10.1113/jphysiol.2010.191098

    DO - 10.1113/jphysiol.2010.191098

    M3 - Article

    C2 - 20519318

    AN - SCOPUS:78751613726

    VL - 588

    SP - 2879

    EP - 2889

    JO - Journal of Physiology

    JF - Journal of Physiology

    SN - 0022-3751

    IS - 15

    ER -